RESEARCH TRIANGLE PARK, North Carolina, September 10 /PRNewswire/ --

- New building in Singapore is home of region's largest clinical development organization

Quintiles Transnational Corp. announced today that it will expand its Singapore operations to meet the surging demand for its business in the Asia-Pacific region. The new regional headquarters will be double the size of its existing presence in Singapore and will be the home of the region's largest clinical development organization. Quintiles' Asia-Pacific growth also has led to expansion of seven local offices in the region and the addition of a new location in Indonesia.

Burst Alert! March 19th was an exciting day for NASA. We know “why” it was special, but we don’t know “why why” it was special. They finally explain the why why today, and you can read all about it in Nature tomorrow. There was something amazing about GRB 080319B and the other cosmic bursts that NASA’s Swift satellite detected that day. (See NASA's animation of what they think happened). "Even by the standards of gamma-ray bursts, this burst was a whopper," says Swift lead scientist Neil Gehrels of NASA. "It blows away every gamma ray burst we’ve seen so far." Here’s the why (we'll get to the why why in a second):

ANTONY, France, September 10 /PRNewswire/ -- Stallergenes S.A. officially inaugurates its new pharmaceutical production unit, located in the Paris area.

Designed to comply with the most stringent EMEA (European Medicines Agency) and FDA (US Food and Drug Administration) standards, this unit will produce desensitisation treatments for all markets, primarily in Europe and North America.

This investment worth more than 20 million euros will incorporate the production of the active substance for the Oralair(R) Grasses tablet and increase the production capacity for Staloral(R), to meet the needs of an expanding international marketplace.

LOS GATOS, California, September 10 /PRNewswire/ --

- FioranoMQ rated best JMS server for performance and stability

Fiorano Software, (www.fiorano.com) a leading provider of business process integration and messaging infrastructure technology announced today that Vodafone, the world's leading mobile telecommunications company chose FioranoMQ for a mission-critical system delivering over 2500 messages/sec to guarantee continued expansion into the mobile market.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071010/NYW049LOGO )

NEW YORK, September 10 /PRNewswire/ -- What: GoldenSource Corporation, a leading provider of enterprise data management (EDM) solutions, is participating in roundtable sessions and a panel discussion at FIMA Asia 2008. Hugh Stewart, vice president, EMEA and Asia, will contribute to a panel discussing the link between quality of reference data and its use as a business enabler. Stewart will also lead interactive roundtables at the conference on critical data management issues impacting financial services companies operating in Asia and how these can be tackled with the adoption of EDM strategies.

Where: FIMA Asia 2008, Orchard Hotel, Singapore

When: FIMA Asia 2008: September 16-17, 2008

SUNNYVALE, California, September 10 /PRNewswire/ --

- TV feature from Telegent used by Latin American journalists at 2008 Beijing Games

Telegent Systems, the company that makes television mobile with its high-performance single-chip mobile TV solutions, today announced that handsets incorporating Telegent's mobile TV technology will soon be available to consumers in Latin America, expanding the global reach of manufacturers that have incorporated the free-to-air TV feature into their handsets. The handsets will provide access to all TV broadcast channels throughout the region, enabling consumers to stay abreast of news, sports and favorite TV programs no matter where they are, and with no investment in infrastructure required by operators or broadcasters.

BRIDGEWATER, New Jersey, September 10 /PRNewswire/ --

- Original Briefing Papers Used by NICE to Shape Its New Cost-Effectiveness Guidelines Offer Unique and Timely Insight for Honing Manufacturer Submissions

SAN FRANCISCO, California (CTIA IT), September 10 /PRNewswire/ -- Acision, the world's leading messaging company, announces the launch of the Acision Innovation Network, a partnership-based ecosystem that will enable the global communications community to collaborate on the creation of new applications and services to advance the way the world communicates.

PARIS, September 10 /PRNewswire/ --

- Abstracts 185 and 1112

Sanofi-aventis, a world leader in diabetes care, announced results from two randomized clinical studies presented at the European Association for the Study of Diabetes (EASD) 44th Annual Meeting demonstrating that the "basal plus" insulin strategy with LANTUS(R) (insulin glargine (rDNA origin) injection) once daily (basal insulin) and APIDRA(R) once daily (prandial insulin) (insulin glulisine (rDNA origin) injection) administered at the main meal (defined by the highest postprandial blood glucose level) improve blood glucose levels in patients with type 2 diabetes after basal insulin optimisation.

PARIS, September 10 /PRNewswire/ --

- Abstracts 186 and 1003

Sanofi-aventis announced today that results from two studies, GINGER and LACE, presented at the 44th annual meeting of the European Association for the Study of Diabetes (EASD) demonstrated that a basal-bolus insulin regimen with LANTUS(R) (insulin glargine (rDNA origin) injection) once daily (basal insulin) and rapid-acting APIDRA(R) (insulin glulisine [rDNA origin] injection) at mealtime (bolus insulin) produced greater A1C reductions versus pre-mixed insulin in people with type 2 diabetes. Both studies, GINGER (a clinical trial) and LACE (real life patient data) confirmed the superior efficacy of LANTUS(R)/APIDRA(R) basal-bolus therapy when compared to pre-mixed insulin regimens.